Cognitive & Nootropic Peptide Reference

A porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids, approved in over 40 countries for stroke recovery and traumatic brain injury.

A hexapeptide analog of angiotensin IV that crosses the blood-brain barrier and promotes synaptogenesis via hepatocyte growth factor (HGF) signaling — studied for cognitive enhancement and neurodegenerative disease.

A naturally occurring tripeptide cleaved from the N-terminus of IGF-1 in the brain, studied as a neuroprotective agent in stroke and neurodegeneration models.

An N-acetylated, amidated analog of Selank with improved metabolic stability and enhanced CNS bioavailability — studied for anxiolytic and nootropic effects.

A small peptide fragment derived from ciliary neurotrophic factor (CNTF) that promotes neurogenesis and enhances cognitive function in animal models by crossing the blood-brain barrier.

A seven-amino-acid spadin analog that enhances BDNF signaling by blocking TREK-1 potassium channels, studied in preclinical models for antidepressant and cognitive-enhancing effects.

A synthetic heptapeptide analog of tuftsin, developed at the Russian Institute of Molecular Genetics as an anxiolytic nootropic administered intranasally.

A synthetic heptapeptide fragment of ACTH (4-10) developed in Russia as a cognitive enhancer, used clinically there for stroke recovery and anxiety.